Technical Analysis for PULM - Pulmatrix, Inc.

Grade Last Price % Change Price Change
C 1.54 -5.52% -0.09
PULM closed down 5.52 percent on Friday, February 26, 2021, on 1.37 times normal volume. It was able to find support at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical PULM trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -5.52%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.52%
Older End-of-Day Signals for PULM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
50 DMA Support 1 day ago
Down 5% 1 day ago
2x Volume Pace 1 day ago
1.5x Volume Pace 1 day ago
Down 3% 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Pulmatrix, Inc., a clinical stage biopharmaceutical company, engages in developing inhaled therapies to address serious pulmonary diseases using its iSPERSE technology. The company's proprietary product pipeline focuses on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with cystic fibrosis, as well as PUR1500, an inhaled product for the treatment of idiopathic pulmonary fibrosis. It is also developing PUR0200, a branded generic in clinical development for chronic obstructive pulmonary disease and other treatments. Pulmatrix, Inc. is based in Lexington, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Development Organ Systems Rare Diseases Pulmonary Disease Cystic Fibrosis Chronic Obstructive Pulmonary Disease Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Pulmonology Treatment Of Idiopathic Pulmonary Fibrosis Interstitial Lung Disease Pulmonary Rehabilitation

Is PULM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.04
52 Week Low 0.9
Average Volume 2,458,729
200-Day Moving Average 1.39
50-Day Moving Average 1.51
20-Day Moving Average 1.79
10-Day Moving Average 1.81
Average True Range 0.23
ADX 35.65
+DI 30.28
-DI 23.88
Chandelier Exit (Long, 3 ATRs ) 2.36
Chandelier Exit (Short, 3 ATRs ) 2.05
Upper Bollinger Band 2.35
Lower Bollinger Band 1.23
Percent B (%b) 0.28
BandWidth 62.40
MACD Line 0.05
MACD Signal Line 0.11
MACD Histogram -0.0628
Fundamentals Value
Market Cap 52.99 Million
Num Shares 34.4 Million
EPS -2.47
Price-to-Earnings (P/E) Ratio -0.62
Price-to-Sales 2.58
Price-to-Book 1.87
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.86
Resistance 3 (R3) 1.87 1.77 1.80
Resistance 2 (R2) 1.77 1.69 1.77 1.78
Resistance 1 (R1) 1.66 1.64 1.61 1.65 1.77
Pivot Point 1.56 1.56 1.54 1.56 1.56
Support 1 (S1) 1.45 1.48 1.40 1.44 1.31
Support 2 (S2) 1.35 1.43 1.35 1.30
Support 3 (S3) 1.24 1.35 1.28
Support 4 (S4) 1.23